v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Total Revenue $ 529,417 $ 449,874
Cost of Goods Sold (117,463) (93,092)
Gross Profit 411,954 356,782
Operating Costs and Expenses:    
Selling, General and Administrative 1,334,975 2,128,417
Research and Development 169,221 73,883
Impairment Expense 99,700
Loss From Operations (1,191,942) (1,845,518)
Other Expense:    
Interest Expense (502,730) (103,693)
Gain on Forgiveness of Debt 300,000 343,938
Loss on Extinguishment of Debt (1,235,000)
Unrealized Gain on Derivative/Warrant Liability 287,704 5,611
Net Loss (1,106,968) (2,834,662)
Net Loss Available to Common Stockholders $ (1,150,431) $ (2,834,662)
Net Loss per Common Share, Basic $ (0.26) $ (0.64)
Net Loss per Common Share, Diluted $ (0.26) $ (0.64)
Shares Used in Computing Net Loss per Common Share, Basic 4,477,297 4,460,535
Shares Used in Computing Net Loss per Common Share, Diluted 4,477,297 4,460,535
Series A-1 Preferred Stock [Member]    
Other Expense:    
Cumulative Series A-1 Convertible Preferred Stock Dividend Requirement $ (43,463)
Product [Member]    
Total Revenue 529,417 434,124
Product Sales Related Parties [Member]    
Total Revenue $ 15,750